Definium Therapeutics Inc logo

Definium Therapeutics Inc

DFTX
Healthcare|Biotechnology|USA
$47.07
-1.37 (-2.83%)
Tangible Book
$2.49

About

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Stock Price

+481.1%(1Y)

Pipeline Summary

9 total trials
1
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
Active: 3Completed: 4Recruiting: 2

Active Trials (5)

A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
NCT06741228Generalized Anxiety Disorder
Phase 3Active
Enrollment: 214 participants
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
NCT07592689Major Depressive Disorder
Phase 3Recruiting
Enrollment: 165 participants
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
NCT07303907Autism Spectrum Disorder
Phase 2Recruiting
Enrollment: 20 participants
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
NCT06809595Generalized Anxiety Disorder
Phase 3Active
Enrollment: 245 participants
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)
NCT06941844Major Depressive Disorder
Phase 3Active
Enrollment: 149 participants

BioScore

5.5/10
Watchlist

Ownership

Recent Insider Trades

Sullivan MarkSELL
2026-06-2513,008 shares @ $45.03
Roberts BrandiSELL
2026-06-253,013 shares @ $45.03
Barrow RobertSELL
2026-06-2529,208 shares @ $45.03
Karlin DanielSELL
2026-06-2510,035 shares @ $45.03
Wiley Matthew T.SELL
2026-06-252,867 shares @ $45.03

Recent News

2026-07-08 16:02:22
2026-07-06 21:00:11
2026-06-30 16:02:26
2026-06-25 21:01:55
2026-06-24 18:35:05
Data last updated: Jul 13, 2026, 12:39 PM